Farma Kian | Kian Sector Fund - B price, AI-powered analysis and sentiment

The positive news is that the growth in profitability and stock returns in the pharmaceutical sector indicates an improvement in operational performance.

Jul 28, 2026

All Farma Kian News

nets

3-years Comparison

nets

Financial Stats

29,605.0

NAV

0.96

P/NAV

1,171.0

NAV-P

1,859,725,331,416

Today's Trade Value

63,705,914

Today's Trade Volume

49,112,540

30-Day Average Trade Volume

Performance Overview

1-Week Return

5.14%

1-Month Return

18.81%

1-Year Return

195.63%

5-Year Return

184.34%

Chart Analysis (AI)

Saham has demonstrated exceptional performance with a 1-year return of 128.62%, significantly outpacing shorter-term gains. The 3-month and 6-month returns of 72.81% and 66.07%, respectively, highlight consistent momentum. Recent weekly and monthly returns of 10.64% and 11.2% indicate sustained growth. This strong performance across all timeframes suggests robust management and strategic decision-making. However, such high returns may raise concerns about sustainability. Investors should monitor for potential volatility or overvaluation.

Saham

84,890 IRR

Sarvatam has demonstrated exceptional performance across all trailing return periods, with a 1-year return of 137.31% and strong short-term gains (1-week: 9.82%, 1-month: 13.82%). The funds momentum is evident in its 3-month (63.22%) and 6-month (59.67%) returns, indicating consistent outperformance. This robust growth suggests effective management strategies and potential for continued success. However, investors should monitor for sustainability and potential market corrections. Overall, Sarvatams performance warrants optimism but requires cautious optimism.

Sarvatam

475,863 IRR

Daryoush has demonstrated exceptional performance with a 1-year return of 118.66%, significantly outpacing shorter-term gains. The 3-month and 6-month returns of 55.95% and 53.88%, respectively, highlight consistent growth momentum. Recent weekly and monthly returns of 13.99% and 9.33% indicate sustained positive trends. This strong performance across all timeframes suggests effective management and robust strategies. However, investors should monitor for potential volatility given the high short-term gains.

Daryoush

40,499 IRR

Zars recent performance shows mixed results. While the 1-year return of 135.32% is impressive, short-term returns are concerning. The fund has experienced negative returns over the past 3 months (-5.93%), 6 months (-4.24%), and even the past week (-0.4%). This suggests potential volatility and a recent downturn. The strong 1-month return of 4.97% offers a glimmer of hope, but overall, the recent trend is worrying. Further analysis of the funds strategy and market conditions is necessary to determine the cause of this volatility.

Zar

787,500 IRR

Talas recent performance shows mixed results. While the 1-year return is impressive at 137.04%, recent trends are concerning. The fund has experienced negative returns over the past week (-1.25%), 3 months (-5.78%), and 6 months (-5.84%). Despite a positive 1-month return of 2.88%, the overall short-term trend suggests volatility and potential weakness. The strong long-term performance is overshadowed by recent declines, indicating possible challenges in maintaining growth.

Tala

1,314,101 IRR

Sanas recent performance shows exceptional short-term gains, with a 1-week return of 11.87% and a 1-month return of 20.6%. The 3-month and 6-month returns of 74.04% and 68.82%, respectively, further highlight its strong momentum. The 1-year return of 132.9% is particularly impressive, indicating robust long-term growth. However, such high returns may be unsustainable and could signal potential overvaluation or market volatility. Investors should exercise caution and consider the risks associated with rapid appreciation.

Sana

45,200 IRR

Homans recent performance shows strong short-term gains, with a 10.91% return in the last week and 43.22% over the past three months. The fund has also delivered impressive long-term returns, with a 106.12% gain over the past year. These results indicate effective management and a robust strategy, particularly in capturing market opportunities. However, the high volatility in returns suggests potential risks. Investors should monitor consistency and risk management practices before making decisions.

Homan

24,899 IRR

Rakhsh has demonstrated exceptional performance across all trailing return periods, with a remarkable 92.62% 1-year return. Short-term gains are equally impressive, including a 12.69% 1-week return and a 46.84% 3-month return. The funds consistent outperformance suggests strong management capabilities and effective investment strategies. However, such high returns may not be sustainable long-term, warranting caution. Investors should assess if the funds risk profile aligns with their goals before committing further.

Rakhsh

26,000 IRR

Hamoons recent performance shows exceptional short-term gains, with a 14.5% return in the last week and 65.76% over three months. The one-year return of 117.03% is particularly impressive, indicating strong management and strategic decisions. However, the 6-month return of 61.09% suggests a slight slowdown in momentum. While the fund has demonstrated robust growth, investors should monitor if this pace is sustainable. The management seems effective, but caution is advised to ensure long-term consistency.

Hamoon

23,500 IRR

Nahals recent performance shows mixed results. While the 1-year return of 78.21% is impressive, short-term performance is concerning. The fund has experienced negative returns over the past week (-0.68%), month (-4.28%), and 3 months (-12.44%). This suggests potential volatility or a recent downturn. The 6-month return of 34.09% indicates some recovery, but the overall trend is uncertain. Further analysis of the funds strategy and market conditions is needed to determine the cause of the recent decline.

Nahal

64,118 IRR

SornaFood has demonstrated exceptional performance across all trailing return periods, with a remarkable 175.31% 1-year return and strong short-term gains of 8.35% (1-week), 14.5% (1-month), 84.54% (3-month), and 86.49% (6-month). This consistent outperformance indicates effective management strategies and robust growth potential. The funds ability to deliver high returns across various timeframes suggests it is well-positioned to capitalize on market opportunities, making it an attractive investment option.

SornaFood

26,549 IRR

Bankdar has demonstrated exceptional performance across all trailing return periods, with a remarkable 102.24% 1-year return. The funds short-term performance is equally impressive, with 1-week, 1-month, 3-month, and 6-month returns of 12.23%, 7.59%, 80.93%, and 74.93%, respectively. This consistent outperformance suggests strong management capabilities and effective investment strategies. However, such high returns may not be sustainable long-term, warranting caution. Investors should monitor for potential volatility.

Bankdar

20,516 IRR

Morvarids recent performance shows strong short-term gains, with a 30.91% return over 3 months and 22.34% over 6 months. However, the 1-year return of 2.18% indicates underperformance in the longer term. The funds volatility is evident, with a 8.1% weekly return but only 5.24% monthly. This inconsistency suggests potential risks despite recent highs. While short-term investors might benefit, long-term stability is questionable. The funds management seems to focus on quick gains, which may not sustain over time.

Morvarid

16,690 IRR

Sarvat Saz has demonstrated exceptional short-term performance, with a 12.72% return over the past week and 50.04% over the past three months. The funds one-year return of 86.81% is particularly impressive, indicating strong management and strategic investment decisions. However, the 6-month return of 45.03% suggests a slight slowdown in momentum. While the funds recent performance is outstanding, investors should monitor if this growth is sustainable or if it reflects short-term market fluctuations.

Sarvat Saz

23,193 IRR

Samins recent performance shows impressive short-term gains, with a 13.36% return over the past week and 78.9% over the past three months. The funds one-year return of 147.07% is particularly notable, indicating strong growth. However, the six-month return of 76.38% suggests a slight slowdown in momentum. While the fund has demonstrated robust performance, investors should monitor whether this growth is sustainable in the long term. The funds management appears effective, but caution is advised given the potential for market volatility.

Farma Kian has demonstrated exceptional short-term performance, with a 1-week return of 9.68% and a 1-month return of 26.16%. The funds momentum is further highlighted by its 3-month and 6-month returns of 131.98% and 133.2%, respectively. The 1-year return of 204.77% underscores its strong growth trajectory. However, such high returns may not be sustainable in the long term, and investors should be cautious of potential volatility. The funds performance suggests aggressive management strategies, which could pose risks.

Samans recent performance shows impressive short-term gains, with a 13.97% return over the past week and 67.54% over the past three months. The funds one-year return of 83.48% is particularly notable, indicating strong growth. However, the consistency of these returns needs to be monitored to ensure sustainability. While the fund has demonstrated robust performance, potential investors should consider the volatility and broader market conditions before making a decision.

Kian Sector Fund - B

Statistical info

Financial Stats

News

Latest News

nets

Analytical info

3-years Comparison

nets

Financial Stats

Performance Overview